Stay updated on VVIP in Relapsed Lymphoid Malignancies Clinical Trial
Sign up to get notified when there's something new on the VVIP in Relapsed Lymphoid Malignancies Clinical Trial page.

Latest updates to the VVIP in Relapsed Lymphoid Malignancies Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe webpage has been updated to include new diagnostic tests and procedures related to Non-Hodgkin Lymphoma, specifically mentioning drugs like Prednisone and the study drug Enitociclib (VIP152). Additionally, the revision number has changed, indicating an update in the study's status.SummaryDifference35%
- Check42 days agoChange DetectedThe webpage has been updated to include new details about a clinical study involving the drug Enitociclib (VIP152) and its combination with other treatments for aggressive blood cancers. Key changes include the addition of specific eligibility criteria for participants, updated study timelines, and the involvement of Christopher Melani, MD, from the National Cancer Institute (NCI).SummaryDifference69%
- Check50 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous version (v2.14.2) and last update date of December 20, 2024.SummaryDifference0.2%
- Check78 days agoChange DetectedThe page has removed a notice about heavy traffic affecting certain services and the absence of posted results, while adding a confirmation that results have been submitted.SummaryDifference1.0%
- Check100 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
Stay in the know with updates to VVIP in Relapsed Lymphoid Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VVIP in Relapsed Lymphoid Malignancies Clinical Trial page.